22
Feb 2026
Neutral polymer enables safer DNA delivery into cells
Researchers from Tokyo Metropolitan University have created a new molecule which carries DNA into biological cells, to treat or vaccinate against illnesses.
-
Life can be betterWe are developing drug products isolated from plant extracts
with history in traditional medicine. -
Improving healthImproving health and wellbeing of the people
is our ultimate goal at Mercury Pharmaceuticals. -
ENTREPRENEURIAL MINDSETHands-on approach to manage projects with proactivity and flexibility.
Welcome to Mercury Pharmaceuticals
We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.
OUR Science
The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.
Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.
- NeuroscienceAmong the global leaders in Neuroscience
- OncologyTreatments for niche cancers.
- Research & Development Building a sustainable R&D pipeline.
- Clinical trialsTesting new treatments and ensure their efficacy and safety by conducting clinical trials.
MERCURY trials
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Cancer
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Neuroscience
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
STAY INFORMED!
22
Feb 2026
MRSA and E. coli detected weeks after Potomac sewage spill
Nearly a month after a wastewater pipe broke and spewed hundreds of millions of gallons of raw sewage into the Potomac River just north of Washington, D.C., the latest water testing results from the University of Maryland School of Public Health continue to show high levels of E. coli and S. aureus – commonly called staph, including antibiotic-resistant MRSA.
22
Feb 2026
Grant funds research on prenatal massage for maternal mental health
The Massage Therapy Foundation (MTF) announces the award of a research grant to University of Denver, Denver, Colo. The grant will support a three-year study entitled, "Prenatal Massage: A Complementary Approach for Maternal Health and Mental Health," led by Primary Investigator Galena Rhoades, PhD.
22
Feb 2026
Biochar adsorption of antibiotics depends on molecular structure
Antibiotic pollution in water is a growing global concern, as residues from human medicine, livestock production, and aquaculture can persist in the environment and contribute to the spread of antibiotic resistance.
Why Us?
Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.